Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Avexa Ltd To Partner With Link Healthcare For Development And Commercialisation Of Apricitabine


Thursday, 20 Jun 2013 03:13am EDT 

Avexa Ltd announced that it has signed a binding term sheet with Link Healthcare Pte Ltd (LINK) for the development and commercialization of Avexa’s lead HIV drug apricitabine (ATC). The collaboration covers the development, registration, and commercialization of ATC worldwide, including the markets of North America and Europe but excluding certain territories for which regional partners were previously announced by Avexa. 

Company Quote

0.015
 --
18 Dec 2014